Homocysteine: overview of biochemistry, molecular biology, and role in disease processes.

Brian Fowler
{"title":"Homocysteine: overview of biochemistry, molecular biology, and role in disease processes.","authors":"Brian Fowler","doi":"10.1055/s-2005-872394","DOIUrl":null,"url":null,"abstract":"<p><p>Homocysteine is derived from the essential amino acid methionine and plays a vital role in cellular homeostasis in man. Homocysteine levels depend on its synthesis, involving methionine adenosyltransferase, S-adenosylmethionine-dependent methyltransferases such as glycine N-methyltransferase, and S-adenosylhomocysteine hydrolase; its remethylation to methionine by methionine synthase, which requires methionine synthase reductase, vitamin B (12), and 5-methyltetrahydrofolate produced by methylenetetrahydrofolate reductase or betaine methyltransferase; and its degradation by transsulfuration involving cystathionine beta-synthase. The control of homocysteine metabolism involves changes of tissue content or inherent kinetic properties of the enzymes. In particular, S-adenosylmethionine acts as a switch between remethylation and transsulfuration through its allosteric inhibition of methylenetetrahydrofolate reductase and activation of cystathionine beta-synthase. Mutant alleles of genes for these enzymes can lead to severe loss of function and varying severity of disease. Several defects lead to severe hyperhomocysteinemia, the most common form being cystathionine beta-synthase deficiency, with more than a hundred reported mutations. Less severe elevations of plasma homocysteine are caused by folate and vitamin B (12) deficiency, and renal disease and moderate hyperhomocysteinemia are associated with several common disease states such as cardiovascular disease. Homocysteine toxicity is likely direct or caused by disturbed levels of associated metabolites; for example, methylation reactions through elevated S-adenosylhomocysteine.</p>","PeriodicalId":87139,"journal":{"name":"Seminars in vascular medicine","volume":"5 2","pages":"77-86"},"PeriodicalIF":0.0000,"publicationDate":"2005-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1055/s-2005-872394","citationCount":"152","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Seminars in vascular medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1055/s-2005-872394","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 152

Abstract

Homocysteine is derived from the essential amino acid methionine and plays a vital role in cellular homeostasis in man. Homocysteine levels depend on its synthesis, involving methionine adenosyltransferase, S-adenosylmethionine-dependent methyltransferases such as glycine N-methyltransferase, and S-adenosylhomocysteine hydrolase; its remethylation to methionine by methionine synthase, which requires methionine synthase reductase, vitamin B (12), and 5-methyltetrahydrofolate produced by methylenetetrahydrofolate reductase or betaine methyltransferase; and its degradation by transsulfuration involving cystathionine beta-synthase. The control of homocysteine metabolism involves changes of tissue content or inherent kinetic properties of the enzymes. In particular, S-adenosylmethionine acts as a switch between remethylation and transsulfuration through its allosteric inhibition of methylenetetrahydrofolate reductase and activation of cystathionine beta-synthase. Mutant alleles of genes for these enzymes can lead to severe loss of function and varying severity of disease. Several defects lead to severe hyperhomocysteinemia, the most common form being cystathionine beta-synthase deficiency, with more than a hundred reported mutations. Less severe elevations of plasma homocysteine are caused by folate and vitamin B (12) deficiency, and renal disease and moderate hyperhomocysteinemia are associated with several common disease states such as cardiovascular disease. Homocysteine toxicity is likely direct or caused by disturbed levels of associated metabolites; for example, methylation reactions through elevated S-adenosylhomocysteine.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
同型半胱氨酸:生物化学、分子生物学和疾病过程中的作用概述。
同型半胱氨酸来源于必需氨基酸蛋氨酸,在人体细胞稳态中起着至关重要的作用。同型半胱氨酸水平取决于其合成,包括蛋氨酸腺苷基转移酶、s -腺苷基蛋氨酸依赖的甲基转移酶,如甘氨酸n -甲基转移酶和s -腺苷基同型半胱氨酸水解酶;通过蛋氨酸合成酶将其再甲基化为蛋氨酸,这需要蛋氨酸合成酶还原酶、维生素B(12)和由亚甲基四氢叶酸还原酶或甜菜碱甲基转移酶产生的5-甲基四氢叶酸;它的降解涉及到半胱硫氨酸-合成酶。同型半胱氨酸代谢的控制涉及组织含量或酶的固有动力学性质的改变。特别是,s -腺苷蛋氨酸通过对亚甲基四氢叶酸还原酶的变构抑制和对胱硫氨酸-合成酶的激活,在再甲基化和转硫化之间起切换作用。这些酶基因的等位基因突变可导致严重的功能丧失和疾病的不同严重程度。几种缺陷导致严重的高同型半胱氨酸血症,最常见的形式是胱氨酸-合成酶缺乏症,据报道有一百多种突变。血浆同型半胱氨酸不太严重的升高是由叶酸和维生素B(12)缺乏引起的,肾脏疾病和中度高同型半胱氨酸血症与心血管疾病等几种常见疾病状态有关。同型半胱氨酸毒性可能是直接的或由相关代谢物水平紊乱引起的;例如,甲基化反应通过s -腺苷型同型半胱氨酸升高。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Prevention of stroke in patients with atrial fibrillation: Current strategies and future directions Dear readers Comparability of D-dimer assays in clinical samples. The role of qualitative D-dimer assays, clinical probability, and noninvasive imaging tests for the diagnosis of deep vein thrombosis and pulmonary embolism. Screening for deep vein thrombosis and pulmonary embolism in outpatients with suspected DVT or PE by the sequential use of clinical score: a sensitive quantitative D-dimer test and noninvasive diagnostic tools.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1